# MNPR (Monopar Therapeutics Inc.) - SEC EDGAR Financial Statements

> Monopar Therapeutics Inc. reported $0 in revenue and a net loss of $20.60M for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/MNPR
- Markdown: https://convexityos.com/fundamentals/MNPR.md
- SEC CIK: 0001645469
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:36 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001645469&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$25.49M | Operating profit |
| Net Income | FY 2025 | -$20.60M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $105.1M | Total debt: $357K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | -- | -- | -- | -- | $0 | $0 | $0 | $0 |
| Research & Development | $9.90M | $13.01M | $5.60M | $7.59M | $6.49M | $4.07M | $1.97M | $1.77M | $935K | $280K |
| Total Operating Expenses | $16.70M | $16.16M | $8.83M | $10.54M | $9.13M | $6.51M | $4.32M | $3.33M | $16.60M | $1.19M |
| **Operating Income** | -$16.70M | -$16.16M | -$8.83M | -$10.54M | -$9.13M | -$6.51M | -$4.32M | -$3.33M | -$16.60M | -$1.19M |
| Interest Income | $2.99M | $404K | $429K | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$13.72M | -$15.59M | -$8.40M | -- | -- | -- | -- | -$3.30M | -$16.55M | -- |
| Income Tax Expense | $800 | $800 | $800 | $800 | $0 | $18K | $0 | -$71K | -$3.6K | $800 |
| **Net Income** | -$13.72M | -$15.59M | -$8.40M | -$10.52M | -$9.10M | -$6.30M | -$4.22M | -$3.23M | -$16.55M | -$1.19M |
| Basic EPS | -$1.85 | -$4.11 | -$3.04 | -$4.15 | -$3.65 | -$2.90 | -$2.25 | -$1.75 | -$9.45 | -- |
| **Diluted EPS** | -- | -- | -- | -- | -$3.65 | -$2.90 | -$2.25 | -$1.75 | -$9.45 | -- |
| Basic Shares Outstanding | 7.4M | 3.8M | 2.8M | 2.5M | 2.5M | 2.2M | 1.9M | 1.9M | 1.8M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 2.5M | 2.2M | 1.9M | 1.9M | 1.8M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Research & Development | $4.44M | $4.77M | $3.49M | $3.94M | $2.59M | $1.73M | $1.64M | $9.92M |
| Total Operating Expenses | $7.47M | $6.64M | $5.23M | $6.16M | $4.09M | $3.23M | $3.22M | $11.07M |
| **Operating Income** | -$7.47M | -$6.64M | -$5.23M | -$6.16M | -$4.09M | -$3.23M | -$3.22M | -$11.07M |
| Interest Income | $1.27M | $1.30M | $1.33M | $954K | $655K | $781K | $597K | $149K |
| **Net Income** | -$6.20M | -$5.31M | -$3.89M | -$5.20M | -$3.44M | -$2.45M | -$2.62M | -$10.93M |
| Basic EPS | -$0.72 | -$0.62 | -$0.46 | -- | -$0.48 | -$0.35 | -$0.38 | -- |
| Basic Shares Outstanding | 8.6M | 8.5M | 8.5M | -- | 7.1M | 7.0M | 7.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $61.83M | $45.82M | $7.27M | $8.19M | $20.30M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M |
| Short-Term Investments | $60.88M | $45.53M | $6.54M | $12.18M | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $122.7M | $91.35M | $13.81M | $12.18M | $20.01M | $16.74M | $13.21M | $6.89M | $8.98M | $2.07M |
| Other Current Assets | $64K | $79K | $66K | $46K | $218K | $63K | $16K | -- | -- | -- |
| **Total Current Assets** | $140.5M | $60.29M | $7.33M | $13.17M | $20.52M | $16.80M | $13.23M | $7.25M | $9.13M | $2.10M |
| Other Non-Current Assets | -- | -- | -- | -- | $0 | $69K | $122K | $66K | -- | -- |
| **Total Non-Current Assets** | $255K | $0 | $13K | $61K | $0 | $69K | $122K | $66K | $800K | $800K |
| **Total Assets** | $140.7M | $60.29M | $7.35M | $13.23M | $20.52M | $16.87M | $13.35M | $7.32M | $9.93M | $2.90M |
| **Total Current Liabilities** | $2.74M | $5.25M | $1.76M | $3.13M | $1.58M | $1.18M | $724K | $400K | $312K | $65K |
| **Total Non-Current Liabilities** | $155K | $0 | $0 | $8.4K | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.89M | $5.25M | $1.76M | $3.14M | $1.58M | $1.18M | $724K | $400K | $312K | $65K |
| **Total Debt (incl. Leases)** | $245K | -- | $8.4K | $57K | -- | -- | -- | -- | -- | -- |
| Common Stock | $6.7K | $6.1K | $3.0K | $13K | $13K | $11K | $11K | $9.3K | $9.3K | $0 |
| Retained Earnings | -$89.51M | -$75.79M | -$60.21M | -$51.80M | -$41.29M | -$32.19M | -$25.88M | -$21.66M | -$18.43M | -$1.87M |
| Accumulated Other Comp. Income | $131K | $36K | -$14K | $8.9K | -$3.2K | -$7.9K | -$11K | -$2.4K | $0 | -- |
| **Total Stockholders' Equity** | $137.8M | $55.04M | $5.59M | $10.09M | $18.94M | $15.69M | $12.63M | $6.92M | $9.62M | $2.83M |
| Total Equity | $137.8M | $55.04M | $5.59M | $10.09M | $18.94M | $15.69M | $12.63M | $6.92M | $9.62M | $2.83M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $52.63M | $52.76M | $52.54M | $61.83M | $127.7M | $39.50M | $39.71M | $45.82M |
| Short-Term Investments | $52.49M | $52.61M | $52.37M | $60.88M | $127.5M | $39.33M | $39.51M | $45.53M |
| **Cash & Short-Term Investments** | $105.1M | $105.4M | $104.9M | $122.7M | $255.2M | $78.83M | $79.23M | $91.35M |
| Other Current Assets | $435K | $465K | $251K | $64K | $415K | $497K | $524K | $79K |
| **Total Current Assets** | $129.9M | $134.8M | $137.7M | $140.5M | $144.1M | $53.75M | $55.08M | $60.29M |
| **Total Non-Current Assets** | $367K | $215K | $240K | $255K | $107K | $118K | $9.1K | $0 |
| **Total Assets** | $130.2M | $135.0M | $138.0M | $140.7M | $144.2M | $53.87M | $55.09M | $60.29M |
| **Total Current Liabilities** | $2.98M | $4.02M | $2.46M | $2.74M | $2.57M | $1.58M | -- | $5.25M |
| **Total Non-Current Liabilities** | $200K | $108K | $132K | $155K | $71K | $80K | -- | $0 |
| **Total Liabilities** | $3.18M | $4.12M | $2.59M | $2.89M | $2.64M | $1.66M | $1.49M | $5.25M |
| **Total Debt (incl. Leases)** | $357K | $206K | $230K | $245K | $102K | $114K | $8.3K | -- |
| Common Stock | $6.8K | $6.7K | $6.7K | $6.7K | $6.7K | $6.1K | $6.1K | $6.1K |
| Retained Earnings | -$104.9M | -$98.72M | -$93.40M | -$89.51M | -$84.31M | -$80.87M | -$78.42M | -$75.79M |
| Accumulated Other Comp. Income | $95K | $91K | $99K | $131K | $12K | $78K | -$22K | $36K |
| **Total Stockholders' Equity** | $127.1M | $130.9M | $135.4M | $137.8M | $141.6M | $52.20M | $53.59M | $55.04M |
| Total Equity | $127.1M | $130.9M | $135.4M | $137.8M | $141.6M | $52.20M | $53.59M | $55.04M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.72M | -$15.59M | -$8.40M | -$10.52M | -$9.10M | -$6.30M | -$4.22M | -$3.23M | -$16.55M | -$1.19M |
| Stock-Based Compensation | $4.84M | $1.14M | $1.90M | $1.64M | $1.47M | $1.32M | $1.01M | $529K | $305K | $0 |
| **Operating Cash Flow** | -$12.20M | -$6.40M | -$7.86M | -$7.23M | -$7.32M | -$4.66M | -$3.02M | -$2.68M | -$2.63M | -$1.19M |
| **Investing Cash Flow** | -$63.45M | -$14.34M | $4.93M | -$4.92M | $0 | -- | -- | -- | -- | -- |
| Common Stock Issued | $0 | $4.20M | $2.07M | $109K | -- | $8.18M | $0 | $0 | $4.71M | $0 |
| Share Repurchases | -$35.00M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $91.57M | $59.29M | $2.03M | $33K | $10.88M | $8.18M | $9.35M | -$206K | $9.54M | $1.26M |
| **Net Change in Cash** | $16.02M | $38.55M | -$920K | -$12.12M | $3.57M | $3.52M | $6.32M | -$2.89M | $6.91M | $68K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.20M | -$5.31M | -$3.89M | -$5.20M | -$3.44M | -$2.45M | -$2.62M | -$10.93M |
| Stock-Based Compensation | $2.04M | $1.43M | $1.69M | $1.10M | $1.10M | $1.28M | $1.36M | $279K |
| **Operating Cash Flow** | -$6.17M | -$3.25M | -$3.47M | -$3.06M | -$2.41M | -$1.08M | -$5.66M | -$2.00M |
| **Investing Cash Flow** | $5.46M | $4.12M | -$5.58M | -$62.19M | -$2.13M | $1.19M | -$326K | -$14.34M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $0 | $0 | $1.01M |
| **Financing Cash Flow** | $586K | -$647K | -$200K | -$699K | $92.71M | -$317K | -$116K | $56.14M |
| **Net Change in Cash** | -$123K | $214K | -$9.29M | -$65.84M | $88.18M | -$209K | -$6.10M | $39.80M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -10.0% | -28.3% | -150.4% | -104.2% | -48.1% | -40.2% | -33.5% | -46.7% | -172.1% | -41.9% |
| Return on Assets (ROA) | -9.7% | -25.9% | -114.4% | -79.5% | -44.4% | -37.4% | -31.6% | -44.1% | -166.7% | -40.9% |
| Current Ratio | 51.35x | 11.47x | 4.17x | 4.21x | 12.98x | 14.28x | 18.27x | 18.15x | 29.28x | 32.48x |
| Quick Ratio | 44.86x | 17.39x | 7.86x | 3.89x | 12.66x | 14.22x | 18.25x | 17.25x | 28.80x | 32.13x |
| Debt to Equity | 0.00x | -- | 0.00x | 0.01x | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -16.2% | -13.6% | -11.1% | -10.0% | -13.7% | -33.2% | -30.9% | -28.3% |
| Return on Assets (ROA) | -15.8% | -13.2% | -10.9% | -9.7% | -13.5% | -32.1% | -30.1% | -25.9% |
| Current Ratio | 43.55x | 33.56x | 56.04x | 51.35x | 56.10x | 33.94x | -- | 11.47x |
| Quick Ratio | 35.25x | 26.24x | 42.69x | 44.86x | 99.35x | 49.78x | -- | 17.39x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
